Early and Two-year Outcomes after Sutureless and Conventional Aortic Valve Replacement: a Nationwide Population-based Study

• Published in: Journal of Korean medical science 2021, 36(9), , pp.1-12
• Main Authors: Choi, Jae Woong, Kim, Ho Jin, Kim, Joon Bum, Lee, Sak, Lim, Cheong, Chang, Byung Chul, Suh, Youshin, Lee, Na Rae, Hwang, Ho Young
• Format: Article
• Language: English
• Subjects: Original; 의학일반
• ISSN: 1011-8934; 1598-6357
• DOI: 10.3346/jkms.2021.36.e57

We compared early and 2-year clinical outcomes of sutureless aortic valve replacement (SAVR) with conventional aortic valve replacement (CAVR) in a nationwide study based on claims data. From December 2016 to November 2018, 3,173 patients underwent bioprosthetic aortic valve replacements. SAVR and CAVR were performed in 641 and 2,532 patients, respectively. Propensity score-matched analysis was performed in 640 patient pairs. Operative mortality rate was 2.8% without significant differences between the SAVR (3.4%) and CAVR (2.3%) groups ( = 0.324). There were no significant differences in postoperative morbidities between the groups except for permanent pacemaker (PPM) implantation. PPM implantation rate was significantly higher in the SAVR (3.8%) than in the CAVR group (0.9%) ( < 0.001). One- and two-year overall survival was 89.1% and 87.5%, respectively, without significant differences between the groups (SAVR group vs. CAVR grou = 89.9% and 90.5% vs. 87.2% and 88.7%, respectively; = 0.475). There were no significant differences in the cumulative incidence of cardiac death, stroke, aortic valve reoperation and infective endocarditis between the groups. Cumulative PPM implantation incidence at 6 months in the CAVR was 1.1%, and no patient required PPM implantation after 6 months. In the SAVR, the cumulative PPM implantation incidence at 0.5, one, and two years was 3.9%, 5.0% and 5.6%, respectively. The cumulative PPM implantation rate was higher in the SAVR group than in the CAVR group ( < 0.001). Early and 2-year clinical outcomes between SAVR and CAVR were not different except for a high rate of permanent pacemaker implantation in the SAVR group.